History
- HISTORY
-
- Woojin B&G Co., Ltd., OSP Co., Ltd. strategic investment (KRW 300 million), KST investment (KRW 300 million)
- Signing of MOU with Hanlim Pharmaceutical Co., Ltd. for investment and cooperation in research and develop- ment of new drugs for PDT ('22 06. 03)
- 2018~
2019 -
- ETRI Research Institute Preliminary Startup Support Selection (2018.05)
- Generation Fusion Startup Campus Project Selection (2018.06)/Best Project Evaluation
- Establishment of Dr. I&B Co., Ltd. (2019.02.21)
- Venture Business Certification (2019.04.11)
- Obtained manufacturing license for Class 3 laser inspection equipment (PDToA-153)
- Development of photoreactive cosmetics/LED masks (April~October 2019)
- Selection of R&D support project for startup growth by the Ministry of SMEs and Startups (preclinical testing of animal medicine)
- Completion of the 2nd Pet Industry Top-level Course (Konkuk University)
- 2020
-
- Acquisition of additional manufacturing permit for animal complex laser irradiator (PDToiB-153) Class 3 product
- Dr. Sim Young-gi appointed as CTO of Bio Division
- Woojin B&G Co., Ltd., OSP Co., Ltd. strategic investment (KRW 300 million), KST investment (KRW 300 million)
- Approval of over-the-counter drug for animal inflammation treatment (PhotoCure) (114-A0301)
- Completed Seoul National University Animal Industry Top-level Course ('20.02~08)
- Development of a new 2nd generation photosensitizer drug substance (2nd generation structure, in-vitro test, equivalent effect at 10% of the dose compared to existing foreign products)
- Ministry of SMEs and Startups Startup Growth R&D, “Strategic” Project Selection (2 years/400 million won)
- Development of a new drug substance for 5th generation photosensitizer anticancer treatment (Combination Therapy) in progress ('20.09~)
- 2021
-
- Photomed rodent anticancer efficacy trial (Daegu New Drug Center, Dongduk Women's University Department of Pharmacy)
- Laser market launch for animal dermatitis treatment (Photo Laser)
- Pre-TIPS project selection (Development of nano-new drug substance for animal inflammation/tumor complex treatment, '21.06~22.03)
- Signing of MOU for cooperation in developing PDT clinical technology with Konkuk University Animal Hospital (Cancer Treatment Center) ('21.09.28)
- PhotoMed Patent Material International SCI Academic Paper Announcement ('21.09.29)
- Development of 3rd generation photoresponsive complex anticancer treatment agent/2 patent applications ('21.10.10/11.10)
- Professor Moon Seok-hwan of the Lung Cancer Center at St. Mary's Hospital PDT Clinical Trial Research Collaboration ('21.11.12)
- PhotoMed International Conference Paper Presentation ('21.12.01)
- Konkuk University/Seoul Startup Hub Pet-demoday Grand Prize ('21.12.10)
- 2022
-
- 2022 Regional Specialized R&D Project Selection (Development of Antibody-S pecific Characteristic Conjugated Photoreactive Agent)
- 2022 Industry-Academic Collaboration R&D Preliminary Study Selection (Development of Solid Lipid Nanoparticles for Photodynamic Therapy)
- TIPS R&D project selection ('22.06)
- Signing of MOU with Hanlim Pharmaceutical Co., Ltd. for investment and cooperation in research/development of new drugs for PDT ('22.06.03)
- 2023
-
- IBK Changgong Daejeon 3rd Generation Selection
- Preclinical/clinical progress of new drug for tumor treatment for animals (Safety Assessment Research Institute, Pet New Drug Development Business Group Business Agreement' 23.04.04)